Endogenous coagulation activator compounds —use in...

Details Endogenous coagulation activator compounds —use in... Endogenous coagulation activator compounds —use in...

2007-04-24

2007-04-24

Saucier, Sandra E. (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C436S069000

Reexamination Certificate

active

10302649

ABSTRACT:
The invention concerns contact activators for the endogenous coagulation pathway and their use in exploring coagulation anomalies.The activators of the invention are derivatives of gallic acid, preferably polyethylene glycol gallates.

REFERENCES:
patent: 4797471 (1989-01-01), Teetz et al.
patent: 4994192 (1991-02-01), Corin et al.
patent: 2750560 (1978-05-01), None
patent: 0228625 (1986-12-01), None
patent: 0241314 (1987-10-01), None
patent: 0 525035 (1993-02-01), None
patent: 2370705 (1978-06-01), None
patent: 60 199850 (1985-10-01), None
Krogh et al., “Structure-activity relationships for the analgesic activity of gallic acid derivatives”, Il Farmaco 55 :730-735 (2000).
Howard H. Weetall, Enzymatic Synthesis of Gallic Acid Esters, vol. 11 Applied Biochem. & Biotech., pp. 25-28 (1985).

Affiliated with

Also associated with

Rating

Endogenous coagulation activator compounds —use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endogenous coagulation activator compounds —use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endogenous coagulation activator compounds —use in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3742389